Pharmacokinetics and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor, are not affected by moderate hepatic impairment (Q46338578)
Jump to navigation
Jump to search
scientific article published on 30 September 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pharmacokinetics and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor, are not affected by moderate hepatic impairment |
scientific article published on 30 September 2008 |
Statements
1 reference
Pharmacokinetics and pharmacodynamics of dabigatran etexilate, an oral direct thrombin inhibitor, are not affected by moderate hepatic impairment (English)
1 reference
Joachim Stangier
1 reference
Hildegard Stähle
1 reference
Karin Rathgen
1 reference
Willy Roth
1 reference
Kasra Shakeri-Nejad
1 reference
30 September 2008
1 reference
48
1 reference
12
1 reference
1411-1419
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference